Glaukos Corp (GKOS)
112.44
+1.47
(+1.32%)
USD |
NYSE |
May 15, 15:24
Glaukos Cash from Financing (TTM): 27.06M for March 31, 2024
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 27.06M |
December 31, 2023 | 15.04M |
September 30, 2023 | 8.268M |
June 30, 2023 | 5.007M |
March 31, 2023 | 5.993M |
December 31, 2022 | 6.251M |
September 30, 2022 | 7.339M |
June 30, 2022 | 7.00M |
March 31, 2022 | 23.26M |
December 31, 2021 | 39.26M |
September 30, 2021 | 46.30M |
June 30, 2021 | 48.26M |
March 31, 2021 | 275.74M |
December 31, 2020 | 262.54M |
September 30, 2020 | 231.85M |
June 30, 2020 | 232.69M |
March 31, 2020 | -10.83M |
December 31, 2019 | -9.645M |
September 30, 2019 | 14.36M |
Date | Value |
---|---|
June 30, 2019 | 21.62M |
March 31, 2019 | 24.14M |
December 31, 2018 | 21.58M |
September 30, 2018 | 20.04M |
June 30, 2018 | 6.593M |
March 31, 2018 | 5.537M |
December 31, 2017 | 4.667M |
September 30, 2017 | 4.656M |
June 30, 2017 | 3.261M |
March 31, 2017 | 2.031M |
December 31, 2016 | -1.642M |
September 30, 2016 | -3.052M |
June 30, 2016 | -12.22M |
March 31, 2016 | 102.24M |
December 31, 2015 | 107.11M |
September 30, 2015 | 110.03M |
June 30, 2015 | 120.18M |
March 31, 2015 | 5.448M |
December 31, 2014 | 3.50M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-10.83M
Minimum
Mar 2020
275.74M
Maximum
Mar 2021
62.87M
Average
18.33M
Median
Cash from Financing (TTM) Benchmarks
Boston Scientific Corp | 1.643B |
Globus Medical Inc | -350.48M |
PROCEPT BioRobotics Corp | 170.00M |
Accuray Inc | -3.779M |
Asensus Surgical Inc | 9.626M |